Logo

Dykes Fills Variagenics' New Genomics Position

Nov 14, 1998
Premium

CAMBRIDGE, Mass.--Variagenics announced the appointment of Colin Dykes to the newly created position of vice-president, genomics. Dykes had a 16-year career at Glaxo Wellcome before joining Variagenics, a firm here that identifies clinically important variances in genes that affect drug action. Dykes established Glaxo's first genetics and genomics programs and most recently served as director of its UK Genetics Division. At Variagenics, Dykes will lead research and development in genomics and pharmacogenomics.

Filed under

Informatics
Breaking News
The Scan

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.

EHR Quality Improvement Study Detects Demographic-Related Deficiencies in Cancer Family History Data

In a retrospective analysis in JAMA Network Open, researchers find that sex, ethnicity, language, and other features coincide with the quality of cancer family history information in a patient's record.

Inflammatory Bowel Disease Linked to Gut Microbiome Community Structure Gradient in Meta-Analysis

Bringing together data from prior studies, researchers in Genome Biology track down microbial taxa and a population structure gradient with ties to ulcerative colitis or Crohn's disease.

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.